| Genomic Medicine |
1 |
1 |
| Thromboembolism |
0 |
1 |
| Factor II |
0 |
0.52 |
| Factor V |
0 |
0.52 |
| Cerebrovascular Accident |
0 |
0.38 |
| Adherence |
0 |
0.26 |
| Anticoagulation Therapy |
0 |
0.26 |
| CT Scan |
0 |
0.26 |
| Tissue Plasminogen Activator |
0 |
0.26 |
| Cardiovascular Imaging |
0 |
0.25 |
| Deep Venous Thrombosis |
0 |
0.21 |
| Genetic Testing |
0 |
0.18 |
| Hypertension |
0 |
0.18 |
| Antiphospholipid Syndrome |
0 |
0.13 |
| Antithrombin III Deficiency |
0 |
0.13 |
| Artery |
0 |
0.13 |
| Aspirin |
0 |
0.13 |
| Echocardiography |
0 |
0.13 |
| Genetics |
0 |
0.13 |
| Hemiparesis |
0 |
0.13 |
| Patient History |
0 |
0.13 |
| Protein C Deficiency |
0 |
0.13 |
| Protein S Deficiency |
0 |
0.13 |
| Thorax |
0 |
0.13 |
| Tissue |
0 |
0.13 |
| Venous Thromboembolism (VTE) |
0 |
0.13 |